| http://www.w3.org/ns/prov#value | - This year???s growth also reflects pharmaceutical companies??? success in ???maintaining their pricing practices and competing on the basis of clinical evidence and value??? even as insurance companies and other payers ???seek to limit price increases and boost the use of lower-cost generics,??? he says.
|
